Deficient systemic IFN responses to respiratory infections have been observed in patients with noncontrolled asthma,1, 2, 4, 5 suggesting that type I IFN could be used to improve lung function in asthma. The gene discussed is IFNA1; the disease is respiratory tract infectious disorder.